{
  "input": {
    "mode": "revise",
    "query": {
      "entity": "Gastrointestinal epithelial barrier disorders",
      "relation": "indication"
    },
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_mesalamine",
          "type": "Drug",
          "label": "Mesalamine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_budesonide",
          "type": "Drug",
          "label": "Budesonide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_prednisone",
          "type": "Drug",
          "label": "Prednisone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tocilizumab",
          "type": "Drug",
          "label": "Tocilizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_azathioprine",
          "type": "Drug",
          "label": "Azathioprine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclosporine",
          "type": "Drug",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_loperamide",
          "type": "Drug",
          "label": "Loperamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_probiotics",
          "type": "Drug",
          "label": "Probiotics",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_IL10",
          "type": "Target",
          "label": "Interleukin 10",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_TNF-alpha",
          "type": "Target",
          "label": "Tumor Necrosis Factor-alpha",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_IFN-gamma",
          "type": "Target",
          "label": "Interferon gamma",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_anti-inflammatory",
          "type": "Pathway",
          "label": "Anti-inflammatory Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_immunomodulation",
          "type": "Pathway",
          "label": "Immunomodulation Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_GI_disorder",
          "type": "Disease",
          "label": "Gastrointestinal Epithelial Barrier Disorders",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ot_mesalamine",
          "type": "Target",
          "label": "OffTarget_Mesalamine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_mesalamine",
          "type": "Pathway",
          "label": "RiskPathway_Mesalamine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_mesalamine",
          "type": "Phenotype",
          "label": "AdversePhenotype_Mesalamine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_infliximab",
          "type": "Target",
          "label": "OffTarget_Infliximab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_infliximab",
          "type": "Pathway",
          "label": "RiskPathway_Infliximab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_infliximab",
          "type": "Phenotype",
          "label": "AdversePhenotype_Infliximab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_adalimumab",
          "type": "Target",
          "label": "OffTarget_Adalimumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_adalimumab",
          "type": "Pathway",
          "label": "RiskPathway_Adalimumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_adalimumab",
          "type": "Phenotype",
          "label": "AdversePhenotype_Adalimumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Mesalamine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Infliximab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Adalimumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Budesonide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Prednisone",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Tocilizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Methotrexate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Azathioprine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Loperamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Probiotics",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_mesalamine",
          "target": "target_IL10",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知作用于抗炎介质"
        },
        {
          "source": "drug_infliximab",
          "target": "target_TNF-alpha",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "机制已广泛研究用于相关疾病"
        },
        {
          "source": "drug_adalimumab",
          "target": "target_TNF-alpha",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "与类似机制药物一致"
        },
        {
          "source": "drug_budesonide",
          "target": "target_IL10",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "通过调节抗炎反应的常识"
        },
        {
          "source": "drug_prednisone",
          "target": "target_IFN-gamma",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "具有广泛的免疫抑制作用"
        },
        {
          "source": "drug_ustekinumab",
          "target": "target_IL10",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "影响特定细胞因子通路"
        },
        {
          "source": "drug_tocilizumab",
          "target": "target_IL10",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "主要用于炎症相关性疾病"
        },
        {
          "source": "drug_methotrexate",
          "target": "target_IFN-gamma",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "作为抗炎药物的常见应用"
        },
        {
          "source": "drug_azathioprine",
          "target": "target_IFN-gamma",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "用于免疫调节的药物"
        },
        {
          "source": "drug_cyclosporine",
          "target": "target_IFN-gamma",
          "relation": "acts_on",
          "weight": 0.58,
          "agent": "Proponent",
          "rationale": "用于抑制免疫反应"
        },
        {
          "source": "drug_loperamide",
          "target": "disease_GI_disorder",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "用于对抗腹泻相关的GI病理"
        },
        {
          "source": "drug_probiotics",
          "target": "disease_GI_disorder",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "通过改善肠道微生物群"
        },
        {
          "source": "target_IL10",
          "target": "pathway_anti-inflammatory",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "抗炎通路的核心成分"
        },
        {
          "source": "target_TNF-alpha",
          "target": "pathway_anti-inflammatory",
          "relation": "involved_in",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "关键的炎症介质"
        },
        {
          "source": "target_IFN-gamma",
          "target": "pathway_immunomodulation",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "免疫调节的必要成分"
        },
        {
          "source": "pathway_anti-inflammatory",
          "target": "disease_GI_disorder",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "通过抑制炎症来改善症状"
        },
        {
          "source": "pathway_immunomodulation",
          "target": "disease_GI_disorder",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "影响免疫反应的通路"
        },
        {
          "source": "drug_mesalamine",
          "target": "n_ot_mesalamine",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能存在未知的旁路作用"
        },
        {
          "source": "n_ot_mesalamine",
          "target": "n_rp_mesalamine",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "与潜在风险通路有关"
        },
        {
          "source": "n_rp_mesalamine",
          "target": "n_adv_mesalamine",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致不良表型"
        },
        {
          "source": "n_adv_mesalamine",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将对假设形成反驳"
        },
        {
          "source": "drug_infliximab",
          "target": "n_ot_infliximab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "副作用未完全了解"
        },
        {
          "source": "n_ot_infliximab",
          "target": "n_rp_infliximab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在风险机制关联"
        },
        {
          "source": "n_rp_infliximab",
          "target": "n_adv_infliximab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能产生不良反应"
        },
        {
          "source": "n_adv_infliximab",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "风险对假设产生反驳"
        },
        {
          "source": "drug_adalimumab",
          "target": "n_ot_adalimumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "靶向机制可能有缺陷"
        },
        {
          "source": "n_ot_adalimumab",
          "target": "n_rp_adalimumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路潜在的旁路"
        },
        {
          "source": "n_rp_adalimumab",
          "target": "n_adv_adalimumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致负面后果"
        },
        {
          "source": "n_adv_adalimumab",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "风险的出现可能抵消效益"
        }
      ],
      "round_index": 3
    },
    "history": {
      "round": 3,
      "last_scores": [
        {
          "hypothesis_id": "H1",
          "score": 0.58,
          "components": {
            "mechanism_fit": 0.75,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.6,
            "safety_risk": 0.2,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.29
          },
          "graph_signals": {
            "support_weight": 1.35,
            "contradiction_weight": 1.5,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Potential Adverse Effects",
                "pro": [
                  "drug_mesalamine"
                ],
                "con": [
                  "n_adv_mesalamine"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "已知通过 IL-10 途径作用于抗炎"
            ],
            "safety_risk": [
              "潜在的不良表型风险，提高安全性担忧"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "潜在副作用和风险机制未完全阐明"
          ]
        },
        {
          "hypothesis_id": "H2",
          "score": 0.53,
          "components": {
            "mechanism_fit": 0.75,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.68,
            "indication_plausibility": 0.6,
            "safety_risk": 0.2,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.31
          },
          "graph_signals": {
            "support_weight": 1.35,
            "contradiction_weight": 1.6,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Potential Adverse Effects",
                "pro": [
                  "drug_infliximab"
                ],
                "con": [
                  "n_adv_infliximab"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "已知通过 TNF-α 途径作用于抗炎"
            ],
            "safety_risk": [
              "潜在不良反应的风险，增加了安全性问题"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "副作用机制的不确定性需进一步研究"
          ]
        },
        {
          "hypothesis_id": "H3",
          "score": 0.5,
          "components": {
            "mechanism_fit": 0.75,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.68,
            "indication_plausibility": 0.6,
            "safety_risk": 0.2,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.36
          },
          "graph_signals": {
            "support_weight": 1.35,
            "contradiction_weight": 1.7,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Potential Adverse Effects",
                "pro": [
                  "drug_adalimumab"
                ],
                "con": [
                  "n_adv_adalimumab"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "通过 TNF-α 机制与其他生物制剂共同作用"
            ],
            "safety_risk": [
              "不良表型风险可能抵消效果"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "安全性数据较少"
          ]
        },
        {
          "hypothesis_id": "H4",
          "score": 0.62,
          "components": {
            "mechanism_fit": 0.7,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.9,
            "indication_plausibility": 0.7,
            "safety_risk": 0.2,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.3
          },
          "graph_signals": {
            "support_weight": 1.35,
            "contradiction_weight": 1.5,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "通过 IL-10 途径减少炎症反应"
            ],
            "safety_risk": [
              "相对安全性较高，但需注意个体差异"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "个体反应差异未评估"
          ]
        },
        {
          "hypothesis_id": "H5",
          "score": 0.55,
          "components": {
            "mechanism_fit": 0.7,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.68,
            "indication_plausibility": 0.6,
            "safety_risk": 0.2,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.31
          },
          "graph_signals": {
            "support_weight": 1.35,
            "contradiction_weight": 1.68,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Potential Adverse Effects",
                "pro": [
                  "drug_prednisone"
                ],
                "con": [
                  "n_adv_prednisone"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "作为免疫抑制剂，多方位减轻炎症"
            ],
            "safety_risk": [
              "已知长期风险及副作用"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "长期使用的风险未完全评估"
          ]
        },
        {
          "hypothesis_id": "H6",
          "score": 0.56,
          "components": {
            "mechanism_fit": 0.7,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.68,
            "indication_plausibility": 0.6,
            "safety_risk": 0.2,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.33
          },
          "graph_signals": {
            "support_weight": 1.35,
            "contradiction_weight": 1.66,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Potential Adverse Effects",
                "pro": [
                  "drug_ustekinumab"
                ],
                "con": [
                  "n_adv_ustekinumab"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "通过作用在 IL-10 途径，有助于改善炎症"
            ],
            "safety_risk": [
              "潜在不良反应需关注"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "靶点效应和副作用的关联尚不明确"
          ]
        },
        {
          "hypothesis_id": "H7",
          "score": 0.49,
          "components": {
            "mechanism_fit": 0.7,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.68,
            "indication_plausibility": 0.6,
            "safety_risk": 0.2,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.4
          },
          "graph_signals": {
            "support_weight": 1.35,
            "contradiction_weight": 1.7,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Potential Adverse Effects",
                "pro": [
                  "drug_tocilizumab"
                ],
                "con": [
                  "n_adv_tocilizumab"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "有助于调节免疫应答，适用于相关GI疾病"
            ],
            "safety_risk": [
              "潜在副作用需详尽评估"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "副作用与效益之间的平衡未明确"
          ]
        },
        {
          "hypothesis_id": "H8",
          "score": 0.47,
          "components": {
            "mechanism_fit": 0.65,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.68,
            "indication_plausibility": 0.6,
            "safety_risk": 0.2,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.45
          },
          "graph_signals": {
            "support_weight": 1.35,
            "contradiction_weight": 1.8,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Potential Adverse Effects",
                "pro": [
                  "drug_methotrexate"
                ],
                "con": [
                  "n_adv_methotrexate"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "已知用于免疫调节，抗炎特质"
            ],
            "safety_risk": [
              "副作用需谨慎评估"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "整体安全性与有效性需进一步观察"
          ]
        },
        {
          "hypothesis_id": "H9",
          "score": 0.45,
          "components": {
            "mechanism_fit": 0.65,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.65,
            "indication_plausibility": 0.65,
            "safety_risk": 0.2,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.49
          },
          "graph_signals": {
            "support_weight": 1.35,
            "contradiction_weight": 1.9,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Potential Adverse Effects",
                "pro": [
                  "drug_azathioprine"
                ],
                "con": [
                  "n_adv_azathioprine"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "用于免疫调节，但安全性需关注"
            ],
            "safety_risk": [
              "不良反应未予以清晰评估"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "个体安全性差异"
          ]
        },
        {
          "hypothesis_id": "H10",
          "score": 0.46,
          "components": {
            "mechanism_fit": 0.65,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.68,
            "indication_plausibility": 0.65,
            "safety_risk": 0.2,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.5
          },
          "graph_signals": {
            "support_weight": 1.2,
            "contradiction_weight": 1.9,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Potential Adverse Effects",
                "pro": [
                  "drug_cyclosporine"
                ],
                "con": [
                  "n_adv_cyclosporine"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "作为免疫抑制剂，能够用于消炎"
            ],
            "safety_risk": [
              "副作用需在临床上时刻关注"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "不良表型机制尚待进一步确认"
          ]
        },
        {
          "hypothesis_id": "H11",
          "score": 0.44,
          "components": {
            "mechanism_fit": 0.6,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.65,
            "indication_plausibility": 0.6,
            "safety_risk": 0.2,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.55
          },
          "graph_signals": {
            "support_weight": 0.85,
            "contradiction_weight": 1.2,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Potential Adverse Effects",
                "pro": [
                  "drug_loperamide"
                ],
                "con": [
                  "n_adv_loperamide"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "用于缓解腹泻的对症治疗"
            ],
            "safety_risk": [
              "潜在的不良反应风险"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "长期效果未明确"
          ]
        },
        {
          "hypothesis_id": "H12",
          "score": 0.43,
          "components": {
            "mechanism_fit": 0.6,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.68,
            "indication_plausibility": 0.6,
            "safety_risk": 0.2,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.54
          },
          "graph_signals": {
            "support_weight": 0.75,
            "contradiction_weight": 1.25,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Potential Adverse Effects",
                "pro": [
                  "drug_probiotics"
                ],
                "con": [
                  "n_adv_probiotics"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "改善肠道微生物群，但作用不明确"
            ],
            "safety_risk": [
              "潜在副作用未被充分确认"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "疗效和副作用关系未完全阐明"
          ]
        }
      ]
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "revisions": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "drug_mesalamine",
            "via": [
              "target_IL10",
              "pathway_anti-inflammatory"
            ],
            "to": "disease_GI_disorder",
            "success_criteria": "形成两条不相交路径以增强证据",
            "assignee": "Proponent"
          },
          {
            "type": "stress_test_safety",
            "topic": "AdverseEffects_Mesalamine",
            "expectation": "若风险成立，标注高权重 refutes 边",
            "assignee": "Skeptic"
          },
          {
            "type": "merge_claims",
            "nodes": [
              "n_adv_mesalamine",
              "n_rp_mesalamine"
            ],
            "rationale": "合并不良反应与风险路径，减少争议",
            "assignee": "Proponent"
          }
        ],
        "debate_focus": [
          "从机制角度审视 mesalamine 的副作用与效益",
          "整理现有的冲突，明确不良反应的加入条件"
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "drug_infliximab",
            "via": [
              "target_TNF-alpha",
              "pathway_anti-inflammatory"
            ],
            "to": "disease_GI_disorder",
            "success_criteria": "形成两条不相交路径以增强证据",
            "assignee": "Proponent"
          },
          {
            "type": "stress_test_safety",
            "topic": "AdverseEffects_Infliximab",
            "expectation": "若风险成立，标注高权重 refutes 边",
            "assignee": "Skeptic"
          },
          {
            "type": "merge_claims",
            "nodes": [
              "n_adv_infliximab",
              "n_rp_infliximab"
            ],
            "rationale": "合并不良反应与风险路径，减少争议",
            "assignee": "Proponent"
          }
        ],
        "debate_focus": [
          "分析 infliximab 的长期效果与潜在风险",
          "讨论不同患者群体对 infliximab 的反应差异"
        ]
      },
      {
        "hypothesis_id": "H3",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "drug_adalimumab",
            "via": [
              "target_TNF-alpha",
              "pathway_anti-inflammatory"
            ],
            "to": "disease_GI_disorder",
            "success_criteria": "形成两条不相交路径以增强证据",
            "assignee": "Proponent"
          },
          {
            "type": "stress_test_safety",
            "topic": "AdverseEffects_Adalimumab",
            "expectation": "若风险成立，标注高权重 refutes 边",
            "assignee": "Skeptic"
          },
          {
            "type": "merge_claims",
            "nodes": [
              "n_adv_adalimumab",
              "n_rp_adalimumab"
            ],
            "rationale": "合并不良反应与风险路径，减少争议",
            "assignee": "Proponent"
          }
        ],
        "debate_focus": [
          "讨论 adalimumab 的机制与可能的不良反应",
          "明确安全性数据的不足"
        ]
      }
    ],
    "pruned_hypotheses": [],
    "new_subhypotheses": [],
    "seed_request": {
      "should_regenerate": false,
      "reason": "当前候选之间的冲突及机制连贯性不足，需补充图连接以验证假设，及忠告安全性问题",
      "n": 4
    }
  }
}